Article
Immunology
Xiaomin Cai, Zheng Chen, Caiquan Huang, Jie Shen, Wenxian Zeng, Shuang Feng, Yu Liu, Shiting Li, Ming Chen
Summary: This study aimed to construct a prognostic signature based on glycolysis-related genes (GRGs) for IDH1-associated glioblastoma multiforme (GBM) and investigate its relationship with immunity. Through genomic data analysis and statistical methods, GRGs that were associated with prognosis were identified and a prognostic signature was constructed. Further validation showed that the prognostic signature independently predicted the prognosis of GBM patients and was significantly correlated with clinical characteristics, tumor immunogenicity, and immune infiltration.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Mengqiu Cao, Xiaoqing Wang, Fang Liu, Ke Xue, Yongming Dai, Yan Zhou
Summary: This study explored the performance of a three-component diffusion model in evaluating the degree of malignancy and IDH-1 gene type of gliomas. The results showed that the three-component DWI model can serve as a useful biomarker for detecting microstructural features in gliomas with different grades and IDH-1 mutation statuses.
EUROPEAN RADIOLOGY
(2023)
Review
Immunology
Dongming Yan, Weicheng Li, Qibing Liu, Kun Yang
Summary: The tumor immune microenvironment and immunotherapy in IDH-mutant gliomas have been extensively studied. IDH mutations inhibit immune evasion and T-cell responses, making it a potential target for immunotherapy.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Minjae Kim, Kai Tzu-iunn Ong, Seonah Choi, Jinyoung Yeo, Sooyon Kim, Kyunghwa Han, Ji Eun Park, Ho Sung Kim, Yoon Seong Choi, Sung Soo Ahn, Jinna Kim, Seung-Koo Lee, Beomseok Sohn
Summary: The study evaluated the performance of NLP models in predicting IDH mutation status in diffuse glioma, with BERT GCN showing the highest performance in external validation. BERT GCN was found to have superior performance compared to other NLP models and human readers in predicting IDH mutation status.
EUROPEAN RADIOLOGY
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Xiaorui Su, Xibiao Yang, Huaiqiang Sun, Yanhui Liu, Ni Chen, Shuang Li, Zongyao Huang, Hanbing Shao, Simin Zhang, Qiyong Gong, Qiang Yue
Summary: This study aimed to evaluate the value of MRI biomarkers for the identification of IDH mutation and 1p/19q codeletion in adult patients with diffuse glioma. ADC and CBV models were built to determine the status of IDH mutation and 1p/19q codeletion, and the performance of these models was improved by incorporating metabolite concentrations. The results showed that the ADC model performed well in identifying IDH mutation status, while the CBV model outperformed in predicting 1p/19q codeletion.
JOURNAL OF MAGNETIC RESONANCE IMAGING
(2023)
Article
Biochemistry & Molecular Biology
Shuai Wang, Jingheng Wu, Wujun Zhao, Miaomiao Li, Shaoyi Li
Summary: CEBPB and P4HA2 are upregulated in IDH1 wt gliomas and associated with poor prognosis. CEBPE promotes proliferation and TMZ resistance by inducing P4HA2 expression in glioma cells.
Article
Radiology, Nuclear Medicine & Medical Imaging
Martha Foltyn-Dumitru, Marianne Schell, Aditya Rastogi, Felix Sahm, Tobias Kessler, Wolfgang Wick, Martin Bendszus, Gianluca Brugnara, Philipp Vollmuth
Summary: The intensity normalization of MRI data has a significant impact on the performance of radiomics-based models in predicting molecular glioma subtypes.
EUROPEAN RADIOLOGY
(2023)
Review
Oncology
Julie J. Miller, L. Nicolas Gonzalez Castro, Samuel McBrayer, Michael Weller, Timothy Cloughesy, Jana Portnow, Ovidiu Andronesi, Jill S. Barnholtz-Sloan, Brigitta G. Baumert, Mitchell S. Berger, Wenya Linda Bi, Ranjit Bindra, Daniel P. Cahill, Susan M. Chang, Joseph F. Costello, Craig Horbinski, Raymond Y. Huang, Robert B. Jenkins, Keith L. Ligon, Ingo K. Mellinghoff, L. Burt Nabors, Michael Platten, David A. Reardon, Diana D. Shi, David Schiff, Wolfgang Wick, Hai Yan, Andreas von Deimling, Martin van den Bent, William G. Kaelin, Patrick Y. Wen
Summary: This article discusses the diagnosis and management of IDH-mutant gliomas, as well as new treatment methods and future research directions.
Review
Oncology
M. Platten, L. Bunse, W. Wick
Summary: The development of anticancer vaccines has been hindered by a lack of suitable tumor-specific antigens, while IDH1R132H mutation generates a shared clonal neoepitope recognized by mutation-specific T-helper cells, providing new directions for certain cancer vaccines.
Review
Radiology, Nuclear Medicine & Medical Imaging
Ziqin Han, Qiuying Chen, Lu Zhang, Xiaokai Mo, Jingjing You, Luyan Chen, Jin Fang, Fei Wang, Zhe Jin, Shuixing Zhang, Bin Zhang
Summary: This study revealed a radiogenomic correlation between the presence of the T2-FLAIR mismatch sign on MR images and isocitrate dehydrogenase (IDH) mutation status in adult patients with lower-grade gliomas (LGGs). The T2-FLAIR mismatch sign could potentially serve as a non-invasive imaging biomarker for the selection of patients with IDH-mutant LGGs.
EUROPEAN RADIOLOGY
(2022)
Article
Chemistry, Multidisciplinary
Raluca-Ioana Stefan-van Staden, Catalina Cioates Negut, Sorin Sebastian Gheorghe, Paula Sfirloaga
Summary: Two three-dimensional stochastic microsensors based on single-walled carbon nanotubes (SWCNT) and multi-walled carbon nanotubes (MWCNT) were designed to recognize and quantify IDH1 and IDH2 in biological samples. The microsensor using MWCNT demonstrated the highest sensitivity and recovery rate compared to the ELISA standard method.
Article
Biochemistry & Molecular Biology
Dong Chen, Siyuan Xia, Rukang Zhang, Yuancheng Li, Christopher A. Famulare, Hao Fan, Rong Wu, Mei Wang, Allen C. Zhu, Shannon E. Elf, Rui Su, Lei Dong, Martha Arellano, William G. Blum, Hui Mao, Sagar Lonial, Wendy Stock, Olatoyosi Odenike, Michelle Le Beau, Titus J. Boggon, Chuan He, Jianjun Chen, Xue Gao, Ross L. Levine, Jing Chen
Summary: The study revealed that mutant IDH2 in AML cells commonly has K413 acetylation, which negatively regulates its activity by attenuating dimerization and blocking substrate and cofactor binding. K413 acetylation of mitochondrial mIDH2 is achieved through a series of hierarchical phosphorylation events, optimizing the leukemogenic ability of mIDH2 in AML cells.
Article
Oncology
Zhi Zhang, Weiguo Gu, Mingbin Hu, Guohua Zhang, Feng Yu, Jinbiao Xu, Jianxiong Deng, Linlin Xu, Jinhong Mei, Chunliang Wang, Feng Qiu
Summary: A nomogram was established to predict the diagnosis of glioma grade using Ki-67 expression and serum lymphocytes. Patients with HGG had decreased serum lymphocyte count and increased Ki-67 expression, indicating weakened immune function and more aggressive tumors.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Feng-Min Liu, Yu-Fei Gao, Yanyan Kong, Yihui Guan, Jinsen Zhang, Shuai-Hong Li, Dan Ye, Wenyu Wen, Chuantao Zuo, Wei Hua
Summary: The SUVmax on PET can predict IDH1 mutation with high sensitivity and specificity, supported by reduced glucose consumption in IDH1 mutant gliomas, as evidenced by changes in glucose quantity and metabolic enzyme expression levels.
Article
Radiology, Nuclear Medicine & Medical Imaging
Shiman Wu, Xi Zhang, Wenting Rui, Yaru Sheng, Yang Yu, Yong Zhang, Zhenwei Yao, Tianming Qiu, Yan Ren
Summary: This study aimed to construct a radiomics nomogram based on multiparametric MRI data for predicting IDH and ATRX mutation status in patients with lower-grade gliomas (LrGG). The nomogram showed good performance in predicting IDH and ATRX mutation status, providing a clinically useful approach for noninvasive diagnosis of LrGG patients.
EUROPEAN RADIOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Krissie Lenting, Mohammed Khurshed, Tom H. Peeters, Corina N. A. M. van den Heuvel, Sanne A. M. van Lith, Tessa de Bitter, Wiljan Hendriks, Paul N. Span, Remco J. Molenaar, Dennis Botman, Kiek Verrijp, Arend Heerschap, Mark ter Laan, Benno Kusters, Anne van Ewijk, Martijn A. Huynen, Cornelis J. F. van Noorden, William P. J. Leenders
Article
Clinical Neurology
Rene Aquarius, Antonius de Korte, Debby Smits, Matthew Gounis, Kiek Verrijp, Leon Driessen, William Leenders, Joost de Vries
Article
Biochemistry & Molecular Biology
Tom H. Peeters, Thiele Kobus, Vincent Breukels, Krissie Lenting, Andor Veltien, Arend Heerschap, Tom W. J. Scheenen
ACS CHEMICAL NEUROSCIENCE
(2019)
Article
Oncology
Corina N. A. M. van den Heuvel, Anne van Ewijk, Carolien Zeelen, Tessa de Bitter, Martijn Huynen, Peter Mulders, Egbert Oosterwijk, William P. J. Leenders
FRONTIERS IN ONCOLOGY
(2019)
Article
Pathology
Corina N. A. M. van den Heuvel, Diede L. Loopik, Renee M. F. Ebisch, Duaa Elmelik, Karolina M. Andralojc, Martijn Huynen, Johan Bulten, Ruud L. M. Bekkers, Leon F. A. G. Massuger, Willem J. G. Melchers, Albert G. Siebers, William P. J. Leenders
Article
Neurosciences
Krissie Lenting, Corina N. A. M. van den Heuvel, Anne van Ewijk, Duaa ElMelik, Remco de Boer, Elizabeth Tindall, Ge Wei, Benno Kusters, Maarten te Dorsthorst, Mark ter Laan, Martijn A. Huynen, William P. Leenders
ACTA NEUROPATHOLOGICA COMMUNICATIONS
(2019)
Article
Oncology
Eva-Leonne Gottgens, Corina N. A. M. van den Heuvel, Monique C. de Jong, Johannes H. A. M. Kaanders, William P. J. Leenders, Marleen Ansems, Johan Bussink, Paul N. Span
Article
Oncology
Julia Biedermann, Matthias Preussler, Marina Conde, Mirko Peitzsch, Susan Richter, Ralf Wiedemuth, Khalil Abou-El-Ardat, Alexander Krueger, Matthias Meinhardt, Gabriele Schackert, William P. Leenders, Christel Herold-Mende, Simone P. Niclou, Rolf Bjerkvig, Graeme Eisenhofer, Achim Temme, Michael Seifert, Leoni A. Kunz-Schughart, Evelin Schroeck, Barbara Klink
Article
Oncology
Dirk van den Brand, Sanne A. M. van Lith, Jelske M. de Jong, Mark A. J. Gorris, Valentina Palacio-Castaneda, Stijn T. Couwenbergh, Mark R. G. Goldman, Inge Ebisch, Leon F. Massuger, William P. J. Leenders, Roland Brock, Wouter P. R. Verdurmen
Article
Oncology
Eva-Leonne Gottgens, Marleen Ansems, William P. J. Leenders, Johan Bussink, Paul N. Span
Summary: Cell lines are widely used for research, but the lack of well-characterized cell lines poses challenges for validating published data and applying results to the clinic. A study established a database of head and neck squamous cell carcinomas (HNSCC) cell lines, providing tools for studying HNSCC disease and summarizing HPV status, p16 status, radiosensitivity, and hypoxia data. The study found a wide range of sensitivities towards hypoxia and irradiation in the cell lines with diverse characteristics.
Article
Chemistry, Multidisciplinary
Lennard J. M. Dekker, Cassandra Verheul, Nicky Wensveen, William Leenders, Martine L. M. Lamfers, Sieger Leenstra, Theo M. Luider
Summary: The R132H mutation in IDH1 is a crucial prognostic factor for glioma patients. The metabolic changes caused by this mutation were investigated using surgically obtained glioma tissues and corresponding primary cell culture models. Results showed differences in glutamate use and aerobic glycolysis between tissue samples and cell cultures, suggesting the importance of culture conditions and tumor microenvironment in maintaining in vivo metabolic situations.
Article
Oncology
Tom H. Peeters, Krissie Lenting, Vincent Breukels, Sanne A. M. van Lith, Corina N. A. M. van den Heuvel, Remco Molenaar, Arno van Rooij, Ron Wevers, Paul N. Span, Arend Heerschap, William P. J. Leenders
CANCER & METABOLISM
(2019)